Sentence examples for methodological reasons and from inspiring English sources

Although this was provided by the manufacturer in a revised dossier, the G-BA concluded that it was obsolete for methodological reasons and the initially assigned additional benefit rating was not changed [8].

Although this has been attempted in a meticulous study [10], the data on fatty acid uptake appear to be artificially low, presumably for methodological reasons and there is no estimation of triglyceride extraction.

This led to 50 longitudinal studies of which 36 were not comparable for methodological reasons and risk factor selection.

Due to methodological reasons and different definitions of physical restraints [ 3], a wide variation in the reported prevalence could be found.

However, on the one hand, child neglect is not included for methodological reasons, and on the other hand, the number of child abuse victims is not determined on the basis of a population survey, but official information sources are used [ 65].

Because of methodological reasons, clozapine and amisulpride could not be included in the analysis.

Two studies, (Kitaeva et al. 1996; Ying et al. 1997), were not considered reliable for methodological reasons (Speit and Schmid 2006).

For methodological reasons (sample size and lack of statistical representativeness), it is difficult to take these dimensions into account in the qualitative survey.

Each individual age, depositional environment and post-deposition history of the various samples are evaluated, in order to explain the methodological reasons for discordances and concordances.

Due to methodological reasons the IgA1 and IgA2 concentrations detected in this study can not be compared as the data are given in EIA units that are not comparable.

Placebo control may be permissible also in connection with disorders that already have a known effective treatment, when there are compelling and scientifically sound methodological reasons for its use and the participants in the study will not face additional risks of serious or irreversible harm from exposure to placebo [ 6, 7].